Ulsan University Hospital
Ulsan, 682-714, South Korea
NCT Number: NCT03523494
Development of lympho-proliferation reticulation quantification using CT.
Looking for future studies?
Notify MeAll sexes
Observational
Ulsan, 682-714, South Korea
It is known that fibrosis of the subcutaneous soft tissue progresses over time in the lymph edema, and this change progresses to reticulation pattern.
Authors will develop a digital subtraction technique for the extraction of lympho-proliferative reticulation using the Housfield unit of non-reticulation structure (bones, muscles, tendons, vessels, nerves) in the axial image of CT.
Based on the medical records, authors will develop an early diagnosing tool by checking the correlation of the values derived the new technique with circumference, multi-frequency bio-electric impedance analysis, ISO sub-stage, and lymphascintigraphy, and qualify the cut-off values showing high sensitivity and specificity through the receiver operating characteristics (ROC) curve analyses.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 week
calculated value of reticulation
Time frame: 1 week
comparative ratio using 1KHz
Time frame: 1 week
stage Ia, Ib, IIa, IIb, IIIa, and IIIb
Time frame: 1 week
Normal: 1; delayed flow, but visible axillary lymph or inguinal lymph node: 2; , invisible axillary lymph or inguinal lymph node: 3: visible dermal backflow: 4
Time frame: 1 week
5cm above and below mid-antecubital or mid-popliteal fossa
Ulsan University Hospital
Other
Feasibility of Lymph Edema-induced Reticulation Subtraction Based on Computerized Tomography.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04897035
Chronic Venous Insufficiency, Hemic and Lymphatic Diseases
Los Altos, California, United States
View Trial DetailsNCT04393168
Hemic and Lymphatic Diseases, Lymphatic Diseases
Zurich, Switzerland
View Trial DetailsNCT05441943
Anastomose, Breast Cancer
Odense, Region Syddanmark, Denmark
View Trial DetailsNCT07414615
Hemic and Lymphatic Diseases, Lymphatic Diseases
Istanbul, Turkey (Türkiye)
View Trial Details